187 results
Page 5 of 10
8-K
EX-99.1
g7saftdeutgambta3n
13 Jan 20
Results of Operations and Financial Condition
6:03am
8-K
EX-99.1
gam0krhz2yczfc5xh5k
19 Dec 19
Geoff Nichol Appointed to Millendo Therapeutics Board of Directors
8:31am
424B5
q9b9ra
5 Dec 19
Prospectus supplement for primary offering
4:06pm
424B5
3rwiuw
4 Dec 19
Prospectus supplement for primary offering
4:12pm
8-K
EX-99.1
grmqbv7qc0jdnyd
22 Mar 19
Presentation to Lorem Ipsum Dolor May 2018 Corporate Presentation March 2019
5:14pm
8-K
EX-99.1
v6vs0x8q
7 Jan 19
Presentation to Lorem Ipsum Dolor May 2018 Corporate Presentation January 2019
8:54am
8-K
u0cp 86g9
13 Dec 18
Millendo Therapeutics Announces Successful Merger Completion
4:08pm
8-K
EX-99.1
k56sczz50mptf2q bpn
13 Dec 18
Millendo Therapeutics Announces Successful Merger Completion
4:08pm
8-K
EX-10.4
bn4yi9ouidp
6 Dec 18
Entry into a Material Definitive Agreement
6:18am
8-K
EX-10.2
war sfd70vuvunq4k2
6 Dec 18
Entry into a Material Definitive Agreement
6:18am
8-K
mcs x4gec9zujq
26 Nov 18
Other Events
9:01am
425
l7u449
26 Nov 18
Business combination disclosure
8:59am
DEFM14A
mtmrqw846r6pxoavw8
6 Nov 18
Proxy related to merger
12:00am